Varies

Varies is an emerging biotechnology company focused on accelerating drug discovery and development through its proprietary computational and experimental platform. The company leverages advanced machine learning algorithms integrated with high-throughput biological screening to identify novel therapeutic targets and optimize lead candidates across multiple modalities, including small molecules and biologics. By bridging the gap between digital prediction and wet-lab validation, Varies aims to reduce the time and cost associated with bringing life-changing therapies to patients. Their current internal pipeline is focused on high-need areas within oncology and immunology, while also seeking strategic partnerships to expand the reach of their technology.